CCCC · CIK 0001662579 · operating
C4 Therapeutics, Inc. (CCCC) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $262 million, C4 Therapeutics, Inc. is a micro-cap company. The stock currently trades at $3.15, up 16.46% today, with a 52-week range of $1.08–$3.65.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-1.27 | $-1.27 | +16.4% | |
| 2024 | $-1.52 | $-1.52 | +43.1% | |
| 2023 | $-2.67 | $-2.67 | -1.9% | |
| 2022 | $-2.62 | $-2.62 | -44.0% | |
| 2021 | — | $-1.82 | +68.8% | |
| 2020 | — | $-5.83 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-26 | 0001628280-26-012000 | SEC ↗ |
| 2024-12-31 | 2025-02-27 | 0001628280-25-008433 | SEC ↗ |
| 2023-12-31 | 2024-02-22 | 0001628280-24-006144 | SEC ↗ |
| 2022-12-31 | 2023-02-23 | 0001628280-23-004711 | SEC ↗ |
| 2021-12-31 | 2022-02-24 | 0001564590-22-006499 | SEC ↗ |
| 2020-12-31 | 2021-03-11 | 0001564590-21-012531 | SEC ↗ |